chr2-177680861-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_016953.4(PDE11A):​c.2388C>T​(p.Tyr796=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00413 in 1,592,232 control chromosomes in the GnomAD database, including 224 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 106 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 118 hom. )

Consequence

PDE11A
NM_016953.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.749
Variant links:
Genes affected
PDE11A (HGNC:8773): (phosphodiesterase 11A) The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PDE11A-AS1 (HGNC:40433): (PDE11A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-177680861-G-A is Benign according to our data. Variant chr2-177680861-G-A is described in ClinVar as [Benign]. Clinvar id is 787776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.749 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0738 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PDE11ANM_016953.4 linkuse as main transcriptc.2388C>T p.Tyr796= synonymous_variant 16/20 ENST00000286063.11 NP_058649.3
PDE11A-AS1NR_136171.1 linkuse as main transcriptn.104+7436G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PDE11AENST00000286063.11 linkuse as main transcriptc.2388C>T p.Tyr796= synonymous_variant 16/201 NM_016953.4 ENSP00000286063 P1Q9HCR9-1
PDE11A-AS1ENST00000653062.1 linkuse as main transcriptn.366-17568G>A intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.0219
AC:
3319
AN:
151798
Hom.:
106
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0759
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00728
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.000500
Gnomad OTH
AF:
0.0158
GnomAD3 exomes
AF:
0.00568
AC:
1419
AN:
250010
Hom.:
60
AF XY:
0.00429
AC XY:
579
AN XY:
135106
show subpopulations
Gnomad AFR exome
AF:
0.0774
Gnomad AMR exome
AF:
0.00337
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000296
Gnomad FIN exome
AF:
0.0000467
Gnomad NFE exome
AF:
0.000168
Gnomad OTH exome
AF:
0.00279
GnomAD4 exome
AF:
0.00226
AC:
3250
AN:
1440318
Hom.:
118
Cov.:
26
AF XY:
0.00199
AC XY:
1430
AN XY:
717950
show subpopulations
Gnomad4 AFR exome
AF:
0.0785
Gnomad4 AMR exome
AF:
0.00410
Gnomad4 ASJ exome
AF:
0.000154
Gnomad4 EAS exome
AF:
0.0000253
Gnomad4 SAS exome
AF:
0.000210
Gnomad4 FIN exome
AF:
0.0000565
Gnomad4 NFE exome
AF:
0.000130
Gnomad4 OTH exome
AF:
0.00499
GnomAD4 genome
AF:
0.0219
AC:
3331
AN:
151914
Hom.:
106
Cov.:
33
AF XY:
0.0214
AC XY:
1591
AN XY:
74236
show subpopulations
Gnomad4 AFR
AF:
0.0760
Gnomad4 AMR
AF:
0.00721
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000500
Gnomad4 OTH
AF:
0.0157
Alfa
AF:
0.0125
Hom.:
37
Bravo
AF:
0.0245
Asia WGS
AF:
0.00520
AC:
18
AN:
3474
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
PDE11A-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 25, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
7.4
DANN
Benign
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61745593; hg19: chr2-178545589; API